Pages that link to "Q21195884"
Jump to navigation
Jump to search
The following pages link to Facioscapulohumeral dystrophy: the path to consensus on pathophysiology (Q21195884):
Displaying 50 items.
- Genome- and Cell-Based Strategies in Therapy of Muscular Dystrophies (Q26741955) (← links)
- Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD) (Q27318439) (← links)
- Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy (Q28069201) (← links)
- Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation (Q28114835) (← links)
- β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy. (Q30394383) (← links)
- miRNA expression in control and FSHD fetal human muscle biopsies (Q35099175) (← links)
- FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1). (Q35103393) (← links)
- Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation (Q35115914) (← links)
- DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy (Q35190362) (← links)
- End-targeting proteomics of isolated chromatin segments of a mammalian ribosomal RNA gene promoter. (Q35312057) (← links)
- Emerging preclinical animal models for FSHD. (Q35582587) (← links)
- Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease (Q35608609) (← links)
- Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD). (Q36105253) (← links)
- Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report (Q36135207) (← links)
- DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy (Q36300839) (← links)
- Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics (Q36305436) (← links)
- Genetic and epigenetic contributors to FSHD. (Q36359473) (← links)
- Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. (Q36833432) (← links)
- Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy. (Q36891155) (← links)
- DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. (Q37021520) (← links)
- Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics (Q37256163) (← links)
- DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis (Q37381271) (← links)
- Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy. (Q37413081) (← links)
- Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease (Q37529679) (← links)
- Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity (Q37730654) (← links)
- Multiple system atrophy: genetic or epigenetic? (Q38303573) (← links)
- Eukaryotic enhancers: common features, regulation, and participation in diseases (Q38365224) (← links)
- Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy (Q38505065) (← links)
- Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy (Q38538325) (← links)
- Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Pract (Q38555425) (← links)
- A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles. (Q38768975) (← links)
- DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD. (Q38867746) (← links)
- BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. (Q41613311) (← links)
- Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies (Q42363358) (← links)
- Conservation and innovation in the DUX4-family gene network (Q42587722) (← links)
- PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle (Q47146410) (← links)
- MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients (Q48131113) (← links)
- High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial. (Q48194600) (← links)
- Spontaneous resolution of retinal vascular abnormalities and macular oedema in facioscapulohumeral muscular dystrophy (Q48294522) (← links)
- Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts (Q48766406) (← links)
- A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy (Q50133251) (← links)
- Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach (Q50889865) (← links)
- NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. (Q52430782) (← links)
- Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle. (Q52714812) (← links)
- Functional domains of the FSHD-associated DUX4 protein. (Q53832566) (← links)
- Tissue-specific activities of the Fat1 cadherin cooperate to control neuromuscular morphogenesis. (Q55094954) (← links)
- Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments (Q58561492) (← links)
- Molecular Therapies for Muscular Dystrophies (Q59358387) (← links)
- Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of facioscapulohumeral muscular dystrophy (Q61448043) (← links)
- Assessment of diaphragm motion using ultrasonography in a patient with facio-scapulo-humeral dystrophy: A case report (Q61809472) (← links)